<?xml version='1.0' encoding='utf-8'?>
<document id="25502512"><sentence text="Enantioselective inhibition of carprofen towards UDP-glucuronosyltransferase (UGT) 2B7." /><sentence text="UDP-glucuronosyltransferases (UGTs)-catalyzed glucuronidation conjugation reaction plays an important role in the elimination of many important clinical drugs and endogenous substances" /><sentence text=" The present study aims to investigate the enantioselective inhibition of carprofen towards UGT isoforms" /><sentence text=" In vitro a recombinant UGT isoforms-catalyzed 4-methylumbelliferone (4-MU) glucuronidation incubation mixture was used to screen the inhibition potential of (R)-carprofen and (S)-carprofen towards multiple UGT isoforms"><entity charOffset="47-68" id="DDI-PubMed.25502512.s4.e0" text="4-methylumbelliferone" /><entity charOffset="70-74" id="DDI-PubMed.25502512.s4.e1" text="4-MU" /><pair ddi="false" e1="DDI-PubMed.25502512.s4.e0" e2="DDI-PubMed.25502512.s4.e0" /><pair ddi="false" e1="DDI-PubMed.25502512.s4.e0" e2="DDI-PubMed.25502512.s4.e1" /></sentence><sentence text=" The results showed that (S)-carprofen exhibited stronger inhibition potential than (R)-carprofen towards UGT2B7" /><sentence text=" However, no significant difference was observed for the inhibition of (R)-carprofen and (S)-carprofen towards other UGT isoforms" /><sentence text=" Furthermore, the inhibition kinetic behavior was compared for the inhibition of (S)-carprofen and (R)-carprofen towards UGT2B7" /><sentence text=" A Lineweaver-Burk plot showed that both (S)-carprofen and (R)-carprofen exhibited competitive inhibition towards UGT2B7-catalyzed 4-MU glucuronidation"><entity charOffset="59-72" id="DDI-PubMed.25502512.s8.e0" text="(R)-carprofen" /><entity charOffset="131-143" id="DDI-PubMed.25502512.s8.e1" text="4-MU" /><pair ddi="false" e1="DDI-PubMed.25502512.s8.e0" e2="DDI-PubMed.25502512.s8.e0" /><pair ddi="false" e1="DDI-PubMed.25502512.s8.e0" e2="DDI-PubMed.25502512.s8.e1" /></sentence><sentence text=" The inhibition kinetic parameter (Ki ) was calculated to be 7" /><sentence text="0 μM and 31" /><sentence text="1 μM for (S)-carprofen and (R)-carprofen, respectively"><entity charOffset="27-40" id="DDI-PubMed.25502512.s11.e0" text="(R)-carprofen" /></sentence><sentence text=" Based on the standard for drug-drug interaction, the threshold for (S)-carprofen and (R)-carprofen to induce a drug-drug interaction is 0"><entity charOffset="86-99" id="DDI-PubMed.25502512.s12.e0" text="(R)-carprofen" /></sentence><sentence text="7 μM and 3" /><sentence text="1 μM, respectively" /><sentence text=" In conclusion, enantioselective inhibition of carprofen towards UDP-glucuronosyltransferase (UGT) 2B7 was demonstrated in the present study" /><sentence text=" Using the in vitro inhibition kinetic parameter, the concentration threshold of (S)-carprofen and (R)-carprofen to possibly induce the drug-drug interaction was obtained"><entity charOffset="81-94" id="DDI-PubMed.25502512.s16.e0" text="(S)-carprofen" /><entity charOffset="99-112" id="DDI-PubMed.25502512.s16.e1" text="(R)-carprofen" /><pair ddi="false" e1="DDI-PubMed.25502512.s16.e0" e2="DDI-PubMed.25502512.s16.e0" /><pair ddi="false" e1="DDI-PubMed.25502512.s16.e0" e2="DDI-PubMed.25502512.s16.e1" /></sentence><sentence text=" Therefore, clinical monitoring of the plasma concentration of (S)-carprofen is more important than (R)-carprofen to avoid a possible drug-drug interaction between carprofen and the drugs mainly undergoing UGT2B7-catalyzed metabolism"><entity charOffset="100-113" id="DDI-PubMed.25502512.s17.e0" text="(R)-carprofen" /></sentence><sentence text="" /></document>